Sharoky Melvin MD's Form 4 filing
INSMED Inc (INSM) · filed Nov 2, 2022
- Accession no.
- 0001182633-22-000002
- Filed
- Nov 2, 2022
- Trade date
- Oct 31-Nov 1, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $527.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sharoky Melvin MDCIK 0001182633 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This is the weighted average purchase price representing the shares purchased at prices ranging from $17.32 to $17.63 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F2
This is the weighted average purchase price representing the shares purchased at prices ranging from $17.68 to $17.70 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.